CIK: 0001958125 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $565,790 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GILD | GILEAD SCIENCES INC | 289,312 | $35,510 | 6.3% | $120.88 | 0.0% | COM | 375558103 |
| BMY | BRISTOL-MYERS SQUIBB CO | 647,899 | $34,948 | 6.2% | $47.53 | 0.0% | COM | 110122108 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 410,700 | $31,414 | 5.6% | $76.49 | — | COM NEW | 107924102 |
| JNJ | JOHNSON & JOHNSON | 120,840 | $25,008 | 4.4% | $197.01 | 0.0% | COM | 478160104 |
| EW | EDWARDS LIFESCIENCES CORP | 187,048 | $15,946 | 2.8% | $82.07 | 0.0% | COM | 28176E108 |
| MLYS | MINERALYS THERAPEUTICS INC | 331,849 | $12,043 | 2.1% | $40.10 | 0.0% | COM | 603170101 |
| ACLX | ARCELLX INC | 156,109 | $10,178 | 1.8% | $79.78 | 0.0% | COMMON STOCK | 03940C100 |
| DYN | DYNE THERAPEUTICS INC | 519,715 | $10,166 | 1.8% | $18.94 | 0.0% | COM | 26818M108 |
| OCUL | OCULAR THERAPEUTIX INC | 714,501 | $8,674 | 1.5% | $12.15 | 0.0% | COM | 67576A100 |
| OLMA | OLEMA PHARMACEUTICALS INC | 267,058 | $6,676 | 1.2% | $17.79 | 0.0% | COM | 68062P106 |
| TERN | TERNS PHARMACEUTICALS INC | 136,958 | $5,533 | 1.0% | $23.11 | 0.0% | COM | 880881107 |
| HTFL | HEARTFLOW INC | 113,857 | $3,319 | 0.6% | $32.19 | 0.0% | COM | 42238D107 |
| FULC | FULCRUM THERAPEUTICS INC | 201,301 | $2,277 | 0.4% | $10.18 | 0.0% | COM | 359616109 |
| BLLN | BILLIONTOONE INC | 25,505 | $2,087 | 0.4% | $101.40 | 0.0% | CL A | 090168105 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| QURE | UNIQURE NV | 288,345 (+1.9%) | $6,900 (-58.2%) | 1.2% | $9.19 | +319.7% | SHS | N90064101 |
| BSX | BOSTON SCIENTIFIC CORP | 360,428 (+37.1%) | $34,367 (+33.9%) | 6.1% | $100.56 | -2.5% | COM | 101137107 |
| GUTS | FRACTYL HEALTH INC | 5,491,866 (+5.3%) | $12,082 (+45.7%) | 2.1% | $1.35 | +18.9% | COM | 35168W103 |
| ELDN | ELEDON PHARMACEUTICALS INC | 1,259,820 (+18.7%) | $1,902 (-30.8%) | 0.3% | $2.84 | -16.2% | COM | 28617K101 |
| HYPR | HYPERFINE INC | 1,320,041 (+92.8%) | $1,293 (+30.2%) | 0.2% | $1.08 | +11.7% | COM CL A | 44916K106 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 154,834 | $35,850 | 6.3% | $201.95 | +12.7% | — | 00287Y109 |
| BBIO | BRIDGEBIO PHARMA INC | 622,729 | $32,345 | 5.7% | $26.37 | +148.9% | — | 10806X102 |
| EXAS | EXACT SCIENCES CORP | 248,987 | $13,622 | 2.4% | $49.96 | +60.7% | — | 30063P105 |
| RNA | AVIDITY BIOSCIENCES INC | 263,256 | $11,470 | 2.0% | $40.43 | +59.8% | — | 05370A108 |
| — | CIDARA THERAPEUTICS INC | 53,333 | $5,107 | 0.9% | $95.76 | — | — | 171757206 |
| KYTX | KYVERNA THERAPEUTICS INC | 586,909 | $3,521 | 0.6% | $4.79 | +55.0% | — | 501976104 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 133,131 | $955 | 0.2% | $42.39 | -72.2% | — | 61559X104 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 27,209 (-61.9%) | $15,410 (-51.7%) | 2.7% | $513.00 | +3.8% | COM NEW | 46120E602 |
| LLY | ELI LILLY & CO | 25,923 (-54.8%) | $27,859 (-36.4%) | 4.9% | $793.52 | +20.4% | COM | 532457108 |
| SLNO | SOLENO THERAPEUTICS INC | 360,340 (-13.8%) | $16,684 (-41.0%) | 2.9% | $64.77 | -15.3% | COM | 834203309 |
| NTRA | NATERA INC | 62,273 (-58.0%) | $14,266 (-40.3%) | 2.5% | $156.65 | +33.2% | COM | 632307104 |
| CYTK | CYTOKINETICS INC | 258,381 (-42.8%) | $16,418 (-33.9%) | 2.9% | $50.21 | +23.9% | COM NEW | 23282W605 |
| GRAL | GRAIL INC | 30,313 (-78.0%) | $2,594 (-68.2%) | 0.5% | $38.21 | +126.1% | COM | 384747101 |
| IRON | DISC MEDICINE INC | 110,427 (-49.0%) | $8,769 (-38.7%) | 1.5% | $57.71 | +46.4% | COM | 254604101 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 162,550 (-44.2%) | $3,739 (-57.3%) | 0.7% | $34.43 | -4.5% | COM | 90400D108 |
| ASND | ASCENDIS PHARMA A/S | 119,265 (-17.7%) | $25,432 (-11.8%) | 4.5% | $137.67 | — | SPONSORED ADR | 04351P101 |
| REGN | REGENERON PHARMACEUTICALS | 29,797 (-15.7%) | $22,999 (+15.7%) | 4.1% | $564.28 | +20.3% | COM | 75886F107 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 698,996 (-38.1%) | $11,596 (-12.7%) | 2.0% | $7.47 | +91.2% | COM | 71722W107 |
| TARA | PROTARA THERAPEUTICS INC | 1,446,254 (-3.6%) | $7,709 (+18.1%) | 1.4% | $3.30 | +68.3% | COM STK | 74365U107 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | 257,465 (-10.3%) | $12,796 (-6.7%) | 2.3% | $40.27 | +20.7% | COM | 868459108 |
| DNTH | DIANTHUS THERAPEUTICS INC | 653,572 (-2.1%) | $26,934 (+2.5%) | 4.8% | $25.71 | +50.8% | COM | 252828108 |
| GPCR | STRUCTURE THERAPEUTICS INC | 252,901 (-61.2%) | $17,589 (-3.6%) | 3.1% | $25.23 | — | SPONSORED ADS | 86366E106 |
| ABVX | ABIVAX SA | 98,514 (-39.2%) | $13,285 (-3.5%) | 2.3% | $84.90 | — | SPONSORED ADS | 00370M103 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 10,452 (-13.0%) | $1,094 (+45.3%) | 0.2% | $44.59 | +91.3% | COM | 697947109 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,196,807 (-25.9%) | $25,145 (+1.2%) | 4.4% | $13.56 | +28.7% | COM | 87164F105 |
| ADMA | ADMA BIOLOGICS INC | 564,461 (-17.5%) | $10,296 (+2.6%) | 1.8% | $19.85 | -15.1% | COM | 000899104 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | 821,195 (-7.2%) | $13,336 (+0.7%) | 2.4% | $8.47 | +92.7% | COM | 00650F109 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SEPN | SEPTERNA INC | 294,360 | $8,207 | 1.5% | $23.65 | +1.0% | COM | 81734D104 |
| OM | OUTSET MED INC | 118,279 | $439 | 0.1% | $11.92 | -28.1% | COM NEW | 690145206 |
| MGX | METAGENOMI INC | 528,993 | $857 | 0.2% | $2.41 | -10.3% | COM | 59102M104 |
| — | ATAI BECKLEY NV | 196,858 | $805 | 0.1% | $1.33 | — | SHS | N0731H103 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 142,984 | $1,052 | 0.2% | $8.54 | -28.4% | COM NEW | 48576U205 |
| SNSE | SENSEI BIOTHERAPEUTICS INC | 14,718 | $157 | 0.0% | $7.18 | +34.6% | COM NEW | 81728A207 |